Early-career and fellow gynecologic oncologists perceive underpreparedness for the business of medicine: A Society of gynecologic oncology survey study.

Autor: Dholakia J; Division of Gynecologic Oncology, ECU Health, Greenville, NC, USA., Boyd LR; Division of Gynecologic Oncology, NYU Grossman School of Medicine, New York, NY, USA., Agarwal R; Division of Gynecologic Oncology, SUNY Upstate Medical University, Syracuse, NY, USA., Moss H; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Duke Cancer Institute, Durham, NC, USA., Ko EM; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, PA, USA., Aviki E; Division of Gynecologic Oncology, NYU Grossman School of Medicine, New York, NY, USA., Liang MI; Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Publikováno v: Gynecologic oncology reports [Gynecol Oncol Rep] 2024 Sep 21; Vol. 55, pp. 101501. Date of Electronic Publication: 2024 Sep 21 (Print Publication: 2024).

The application and uses of telemedicine in vascular surgery: A narrative review.

Autor: Haran C; Department of Vascular Surgery, Waikato Hospital, 183 Pembroke Street, Hamilton 3204, New Zealand; Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand., Allan P; Department of Vascular Surgery, Waikato Hospital, 183 Pembroke Street, Hamilton 3204, New Zealand., Dholakia J; Department of Vascular Surgery, Waikato Hospital, 183 Pembroke Street, Hamilton 3204, New Zealand., Lai S; Department of Vascular Surgery, Waikato Hospital, 183 Pembroke Street, Hamilton 3204, New Zealand; Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand., Lim E; Department of Vascular Surgery, Waikato Hospital, 183 Pembroke Street, Hamilton 3204, New Zealand., Xu W; Department of Vascular Surgery, Waikato Hospital, 183 Pembroke Street, Hamilton 3204, New Zealand., Hart O; Department of Vascular Surgery, Waikato Hospital, 183 Pembroke Street, Hamilton 3204, New Zealand; Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand., Cain J; Department of Vascular Surgery, Waikato Hospital, 183 Pembroke Street, Hamilton 3204, New Zealand., Narayanan A; Department of Vascular Surgery, Waikato Hospital, 183 Pembroke Street, Hamilton 3204, New Zealand; Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand., Khashram M; Department of Vascular Surgery, Waikato Hospital, 183 Pembroke Street, Hamilton 3204, New Zealand; Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand. Electronic address: manar.khashram@gmail.com.

Publikováno v: Seminars in vascular surgery [Semin Vasc Surg] 2024 Sep; Vol. 37 (3), pp. 290-297. Date of Electronic Publication: 2024 Jul 31.

DKK1 is a predictive biomarker for response to DKN-01: Results of a phase 2 basket study in women with recurrent endometrial carcinoma.

Autor: Arend R; University of Alabama at Birmingham, Birmingham, AL, USA. Electronic address: rarend@uabmc.edu., Dholakia J; University of Alabama at Birmingham, Birmingham, AL, USA., Castro C; Massachusetts General Hospital, Boston, MA, USA., Matulonis U; Dana-Farber Cancer Institute, Boston, MA, USA., Hamilton E; Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN, USA., Jackson CG; The University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA., LyBarger K; Sarah Cannon-Research Institute at HCA Midwest, Kansas City, MO, USA., Goodman HM; Florida Cancer Specialists, West Palm Beach, FL, USA., Duska LR; University of Virginia School of Medicine, Charlottesville, VA, USA., Mahdi H; Cleveland Clinic, Cleveland, OH, USA., ElNaggar AC; West Cancer Center, Memphis, TN, USA., Kagey MH; Leap Therapeutics, Inc., Cambridge, MA, USA., Liu A; Leap Therapeutics, Inc., Cambridge, MA, USA., Piper D; Leap Therapeutics, Inc., Cambridge, MA, USA., Barroilhet LM; University of Wisconsin Hospitals and Clinics, Madison, WI, USA., Bradley W; Froedtert and Medical College of Wisconsin, Milwaukee, WI, USA., Sachdev J; HonorHealth Research Institute, Scottsdale, AZ, USA., Sirard CA; Leap Therapeutics, Inc., Cambridge, MA, USA., O'Malley DM; Ohio State University, Columbus, OH, USA., Birrer M; University of Alabama at Birmingham, Birmingham, AL, USA.

Publikováno v: Gynecologic oncology [Gynecol Oncol] 2023 May; Vol. 172, pp. 82-91. Date of Electronic Publication: 2023 Mar 29.

Identity-related experiences of Asian American trainees in gynecologic oncology.

Autor: Dholakia J; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL, United States., Lee YW; Department of Obstetrics and Gynecology, Boston University Medical Center, Boston, MA, United States., Lu KH; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Huh WK; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL, United States., Yamada SD; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Chicago, Chicago, IL, United States., Fuh KC; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California, San Francisco, San Francisco, CA, United States., Kumar AS; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN, United States., Liang MI; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, West Hollywood, CA, United States., Nair N; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Louisiana State University, New Orleans, LA, United States., Kim KH; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, West Hollywood, CA, United States.

Publikováno v: Gynecologic oncology reports [Gynecol Oncol Rep] 2022 Nov 06; Vol. 44, pp. 101097. Date of Electronic Publication: 2022 Nov 06 (Print Publication: 2022).

Development of Delivery Systems for Local Administration of Cytokines/Cytokine Gene-Directed Therapeutics: Modern Oncologic Implications.

Autor: Dholakia J; Department of Obstetrics & Gynecology, University of Alabama Division of Gynecologic Oncology, 1700 6th Avenue South, Room 10250, Birmingham, AL, 35249-7333, USA. jjdholakia@uabmc.edu., Cohen AC; Department of Obstetrics & Gynecology, Washington University in St. Louis Division of Gynecologic Oncology, St. Louis, MO, USA., Leath CA 3rd; Department of Obstetrics & Gynecology, University of Alabama Division of Gynecologic Oncology, 1700 6th Avenue South, Room 10250, Birmingham, AL, 35249-7333, USA., Evans ET; Department of Obstetrics & Gynecology, University of Alabama Division of Gynecologic Oncology, 1700 6th Avenue South, Room 10250, Birmingham, AL, 35249-7333, USA., Alvarez RD; Department of Obstetrics & Gynecology, Vanderbilt University Division of Gynecologic Oncology, Nashville, TN, USA., Thaker PH; Department of Obstetrics & Gynecology, Washington University in St. Louis Division of Gynecologic Oncology, St. Louis, MO, USA.

Publikováno v: Current oncology reports [Curr Oncol Rep] 2022 Apr; Vol. 24 (4), pp. 389-397. Date of Electronic Publication: 2022 Feb 10.